<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Chem Eng and Analytical Science</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6E67417F-B80E-4C95-BF96-FB92B017EF03"><gtr:id>6E67417F-B80E-4C95-BF96-FB92B017EF03</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Gardiner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9568DA5F-F005-4BE0-8B29-F81BFE9D2AB0"><gtr:id>9568DA5F-F005-4BE0-8B29-F81BFE9D2AB0</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:surname>Curtis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D5488AA4-57C7-4C4B-82D2-8DFFC459C522"><gtr:id>D5488AA4-57C7-4C4B-82D2-8DFFC459C522</gtr:id><gtr:firstName>Gillian</gtr:firstName><gtr:surname>Stephens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FD002826%2F1"><gtr:id>1278F429-8C5C-49B6-86E7-E59869FB940F</gtr:id><gtr:title>Novel biocatalytic reductions for synthesis of chiral amines</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/D002826/1</gtr:grantReference><gtr:abstractText>Chiral amines are used very widely as chemical intermediates to produce drug molecules. Chiral amines exist in more than one form, called enantiomers, and often only one of them is suitable for use in medicine. However, it is extremely difficult to produce the required enantiomer of many chiral amines by standard chemical techniques. It is much better to use enzymes to produce amines, because many enzymes produce pure enantiomers. However, there are still very few enzymes that are suitable for chiral amine production. In this project, we plan to develop new enzymes to produce chiral amines for drug manufacture. The enzymes are from bacteria that grow without oxygen(anaerobes). These bacteria have very unusual enzymes. The amine-producing enzymes that we have discovered catalyse a wide range of reactions that do not occur in other cells. The project will include purifying and characterising the enzymes. We shall also develop genetically engineered bacteria to use for amine manufacturing, because the anaerobes are not really suitable for use in industry. Ultimately, the new enzymes will make it possible to manufacture existing drugs much more cheaply. Furthermore, it should also become possible to produce new medicines that cannot be made at present.</gtr:abstractText><gtr:technicalSummary>New enzymes will be developed for preparation of chiral amines. New reductases from anaerobic bacteria will be developed for reduction of C-C double bonds and aliphatic nitro groups. The enzymes will be purified and fully characterised, and the corresponding genes will be cloned in E. coli. The substrate ranges and stereoselectivities of the enzymes will be determined, along with their activities, substrate tolerance and stability. Recombinant production strains will be developed, incorporating gene knockouts to eliminate side reactions if required. In addition, metabolically engineered strains will be developed, incorporating nitroalkene reductase and aliphatic nitroreductase for direct conversion of nitroalkenes to enantiopure aminoalkanes. Initial studies will be done to indicate the best routes for industrial implementation of the new biocatalysts.</gtr:technicalSummary><gtr:fund><gtr:end>2010-08-12</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-03-13</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>438955</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Key findings were reported previously</gtr:description><gtr:exploitationPathways>Reported previously</gtr:exploitationPathways><gtr:id>1E813539-047B-4139-ACEB-59AC37881EF6</gtr:id><gtr:sectors><gtr:sector>Chemicals,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D8FDA3C-6402-4FE7-A454-68A290E21528"><gtr:id>7D8FDA3C-6402-4FE7-A454-68A290E21528</gtr:id><gtr:title>A short, chemoenzymatic route to chiral beta-aryl-gamma-amino acids using reductases from anaerobic bacteria.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17ed104468c4b2e84c8ad9595fb15a0a"><gtr:id>17ed104468c4b2e84c8ad9595fb15a0a</gtr:id><gtr:otherNames>Fryszkowska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94C61E99-520A-4F98-B3ED-340EB5E49A56"><gtr:id>94C61E99-520A-4F98-B3ED-340EB5E49A56</gtr:id><gtr:title>Effects of water-miscible ionic liquids on cell growth and nitro reduction using Clostridium sporogenes</gtr:title><gtr:parentPublicationTitle>Green Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d100460a9bfae9b58faafd266692102"><gtr:id>7d100460a9bfae9b58faafd266692102</gtr:id><gtr:otherNames>Dipeolu O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/883171E6-63DB-4B40-9C1A-14577BA0B4DF"><gtr:id>883171E6-63DB-4B40-9C1A-14577BA0B4DF</gtr:id><gtr:title>Asymmetric Reduction of Activated Alkenes by Pentaerythritol Tetranitrate Reductase: Specificity and Control of Stereochemical Outcome by Reaction Optimisation</gtr:title><gtr:parentPublicationTitle>Advanced Synthesis &amp; Catalysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17ed104468c4b2e84c8ad9595fb15a0a"><gtr:id>17ed104468c4b2e84c8ad9595fb15a0a</gtr:id><gtr:otherNames>Fryszkowska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1615-4150</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D5ED5E08-C055-41A3-8764-B0345EF92849"><gtr:id>D5ED5E08-C055-41A3-8764-B0345EF92849</gtr:id><gtr:title>A site-saturated mutagenesis study of pentaerythritol tetranitrate reductase reveals that residues 181 and 184 influence ligand binding, stereochemistry and reactivity.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/945abe6e38e453d4e73469f599c3a072"><gtr:id>945abe6e38e453d4e73469f599c3a072</gtr:id><gtr:otherNames>Toogood HS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3B9D6A0E-B29C-42AD-985D-9760C73A4CC9"><gtr:id>3B9D6A0E-B29C-42AD-985D-9760C73A4CC9</gtr:id><gtr:title>Focused directed evolution of pentaerythritol tetranitrate reductase by using automated anaerobic kinetic screening of site-saturated libraries.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f45bcf355bcd161524c0b93928dae98"><gtr:id>9f45bcf355bcd161524c0b93928dae98</gtr:id><gtr:otherNames>Hulley ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/443DF2E6-5D12-4CC6-B671-A842855233E7"><gtr:id>443DF2E6-5D12-4CC6-B671-A842855233E7</gtr:id><gtr:title>A surprising observation that oxygen can affect the product enantiopurity of an enzyme-catalysed reaction.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17ed104468c4b2e84c8ad9595fb15a0a"><gtr:id>17ed104468c4b2e84c8ad9595fb15a0a</gtr:id><gtr:otherNames>Fryszkowska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFAE0398-FD5E-4A06-9B3B-9A02CF094CAC"><gtr:id>BFAE0398-FD5E-4A06-9B3B-9A02CF094CAC</gtr:id><gtr:title>Reduction of aliphatic nitro groups using an obligately anaerobic whole cell biocatalyst</gtr:title><gtr:parentPublicationTitle>Enzyme and Microbial Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/038f8583ae6e7d1f9d4316b546e718c9"><gtr:id>038f8583ae6e7d1f9d4316b546e718c9</gtr:id><gtr:otherNames>Korbekandi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69E14E6C-EAA2-4775-BEDD-02FB044489C0"><gtr:id>69E14E6C-EAA2-4775-BEDD-02FB044489C0</gtr:id><gtr:title>Active site modifications in pentaerythritol tetranitrate reductase can lead to improved product enantiopurity, decreased by-product formation and altered stereochemical outcome in reactions with a,?-unsaturated nitroolefins</gtr:title><gtr:parentPublicationTitle>Catalysis Science &amp; Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17ed104468c4b2e84c8ad9595fb15a0a"><gtr:id>17ed104468c4b2e84c8ad9595fb15a0a</gtr:id><gtr:otherNames>Fryszkowska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2044-4753</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/014C1F2F-5657-47DD-B4DC-10E751BADBC7"><gtr:id>014C1F2F-5657-47DD-B4DC-10E751BADBC7</gtr:id><gtr:title>Highly enantioselective reduction of beta,beta-disubstituted aromatic nitroalkenes catalyzed by Clostridium sporogenes.</gtr:title><gtr:parentPublicationTitle>The Journal of organic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17ed104468c4b2e84c8ad9595fb15a0a"><gtr:id>17ed104468c4b2e84c8ad9595fb15a0a</gtr:id><gtr:otherNames>Fryszkowska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3263</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/D002826/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>